HOME >> MEDICINE >> NEWS
Chlorine dioxide gas kills dangerous biological contaminants

WEST LAFAYETTE, Ind. -- The same sanitizing agent used to rid federal office buildings of anthrax -- chlorine dioxide gas -- can effectively eliminate deadly bacteria from apples and other fruits and vegetables, according to Purdue University researchers.

Scientists at Purdue began experiments using the gas to kill pathogens found on food long before anthrax was detected in mail sent to offices in New York and Washington, D.C., shortly after the terrorist attacks one year ago. The latest university test measured how effectively different potencies of chlorine dioxide (ClO2) gas used over various periods of time could kill Listeria monocytogenes cells on apples.

Results of the study, published in the September issue of Food Microbiology, demonstrated that the vapor was able to eradicate all of the contaminant on the fruit's skin and significantly reduce the bacteria in the stem cavity and the calyx, said Richard Linton, director of Purdue's Center for Food Safety Engineering and senior author. The calyx is the apple's bottom, directly opposite from the stem cavity.

"We see more and more cases of food-borne diseases associated with fruits and vegetables," Linton said. "Some of this is because we encourage people, especially children and the elderly, to eat more and more of these types of foods for added health benefits. Yet these are two of the groups most susceptible to bacteria on food.

"Just 10 to 100 cells of Listeria on a piece of food can cause illness, and it's possible for 1,000 to 10,000 cells to be on a piece of fruit. We need to develop ways to make food safer; traditional sanitation methods to remove pathogens are not effective enough to meet these new standards."

Although Listeria is relatively rare, it is considered the most deadly of the food-borne pathogens with a 20 percent fatality rate. The Clinton administration issued a "no tolerance" edict for Listeria in processed and ready-to-eat foods, such as hot dogs,
'"/>

Contact: Susan A. Steeves
ssteeves@purdue.edu
765-496-7481
Purdue University
12-Sep-2002


Page: 1 2 3

Related medicine news :

1. Study: Carbon dioxide may find new use in producing medical implants
2. Stem cells repair skills might be link to cancer
3. Energy blocker kills big tumors in rats
4. Universit de Montral study shows superior sound-location skills in the blind
5. Autistic children show outstanding musical skills
6. Heart disease kills more women annually than all cancers combined
7. Concord grape juice improved memory and neuro-motor skills in animal study
8. Freezing technique kills majority of small malignant breast cancers
9. Class on psychological skills helps college athletes perform better, study finds
10. Learning skills greatly limits stress for family caregivers, says Stanford study
11. Phone support group helps older people with HIV/AIDS develop coping skills, new study finds

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Chlorine dioxide gas kills dangerous biological contaminants

(Date:5/21/2013)... Mecklenburg EMS Agency (Medic) and the ... Wellness Fair to educate the public on health initiatives and ... Wednesday, May 22, 2013 from 4:00 pm until 7:00 pm ... Creek Road, Charlotte, NC 29262). , Medic, the ... Mecklenburg County Department of Social Services are working toward ...
(Date:5/21/2013)... 2013 Arizona State University is ... to develop their ideas into solutions, products and ... The university is recruiting participants for AREA48 (Applied ... that provides early-stage entrepreneurs with opportunities to access ... to anyone, ASU is particularly seeking participation from ...
(Date:5/21/2013)... Diversity Focus, a non-profit organization striving to ... in the Creative Corridor region, is releasing results for ... conference on Thursday, May 23rd at 10:30 a.m. ... , The survey is a critical component ... that attract, nurture and retain people of diverse backgrounds, ...
(Date:5/21/2013)... the roles two proteins, thrombospondin-1 and prosaposin, play ... has identified a five-amino acid fragment of prosaposin ... of prostate, breast and lung cancer. The findings ... metastasis in a variety of cancers. , ... at Boston Children,s Hospital, Vivek Mittal, PhD, at ...
(Date:5/21/2013)... York, New York (PRWEB) May 21, 2013 ... Vinci surgery robot lawsuit is nearing its conclusion ... According to Bloomberg.com, during closing statements yesterday, an attorney ... dealership, alleging the company wanted to tie sales and ... do all the training to keep control of surgeons, ...
Breaking Medicine News(10 mins):Health News:Mecklenburg EMS Agency Teams Up with the YMCA of Greater Charlotte and Others to Educate the Public on Health Related Initiatives 2Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 2Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 3Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 4Health News:Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m. 2Health News:Changing cancer's environment to halt its spread 2Health News:Changing cancer's environment to halt its spread 3Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 2Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 3Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 4
(Date:5/21/2013)... 21, 2013 Reportlinker.com announces that ... in its catalogue:   ... Optical Coherence Tomography (OCT) ... OBJECTIVES   BCC,s ... offer synopsis of the current and future ...
(Date:5/21/2013)... and TARRYTOWN, N.Y. , May ... SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced ... published online the positive Phase 2a study results of ... is an investigational monoclonal antibody targeting the alpha subunit ... signaling of both IL-4 and IL-13, drivers of Th2 ...
(Date:5/21/2013)... 21, 2013  Healthcare organizations expanding into emerging markets ... , India and ... no shortcuts.  This is proving particularly challenging, considering the ... must change the dialogue around BRIC, as it is ... and building regional partnerships to build a sustainable business. ...
Breaking Medicine Technology:Global Markets and Technologies for Optical Coherence Tomography (OCT) 2Global Markets and Technologies for Optical Coherence Tomography (OCT) 3Global Markets and Technologies for Optical Coherence Tomography (OCT) 4Global Markets and Technologies for Optical Coherence Tomography (OCT) 5Global Markets and Technologies for Optical Coherence Tomography (OCT) 6Global Markets and Technologies for Optical Coherence Tomography (OCT) 7Global Markets and Technologies for Optical Coherence Tomography (OCT) 8Global Markets and Technologies for Optical Coherence Tomography (OCT) 9Global Markets and Technologies for Optical Coherence Tomography (OCT) 10Global Markets and Technologies for Optical Coherence Tomography (OCT) 11Global Markets and Technologies for Optical Coherence Tomography (OCT) 12Global Markets and Technologies for Optical Coherence Tomography (OCT) 13Global Markets and Technologies for Optical Coherence Tomography (OCT) 14Global Markets and Technologies for Optical Coherence Tomography (OCT) 15Global Markets and Technologies for Optical Coherence Tomography (OCT) 16Global Markets and Technologies for Optical Coherence Tomography (OCT) 17Global Markets and Technologies for Optical Coherence Tomography (OCT) 18Global Markets and Technologies for Optical Coherence Tomography (OCT) 19Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 2Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 3Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 4Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 5Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 6Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine 7Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 2Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 3Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 4
Cached News: